Alnylam Pharmaceuticals, Inc. (ALNY)
NASDAQ: ALNY · Real-Time Price · USD
165.04
+8.39 (5.36%)
At close: Nov 13, 2026, 4:00 PM EST
165.91
+0.87 (0.53%)
After-hours: Nov 13, 2026, 7:59 PM EST
Alnylam Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1,754 | 1,657 | 966.43 | 812.69 | 866.39 | 819.98 |
Short-Term Investments | 1,833 | 1,251 | 1,728 | 1,627 | 1,326 | 1,616 |
Cash & Short-Term Investments | 3,587 | 2,908 | 2,695 | 2,439 | 2,192 | 2,436 |
Cash Growth | 31.66% | 7.94% | 10.46% | 11.27% | -9.98% | 29.94% |
Accounts Receivable | 1,085 | 777.57 | 405.31 | 327.79 | 237.96 | 198.57 |
Receivables | 1,085 | 777.57 | 405.31 | 327.79 | 237.96 | 198.57 |
Inventory | 105.91 | 82.72 | 78.51 | 89.15 | 128.96 | 86.36 |
Prepaid Expenses | 334.6 | 281.89 | 116.96 | 126.38 | 132.92 | 88.08 |
Total Current Assets | 5,113 | 4,051 | 3,295 | 2,983 | 2,692 | 2,809 |
Property, Plant & Equipment | 792.86 | 708.06 | 693.93 | 725.79 | 738.63 | 733.63 |
Long-Term Deferred Tax Assets | 2,007 | 125.98 | 116.86 | 10.1 | - | - |
Other Long-Term Assets | 82.48 | 81.63 | 133.9 | 111.29 | 115.48 | 101.1 |
Total Assets | 7,995 | 4,966 | 4,240 | 3,830 | 3,546 | 3,643 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 135.4 | 115.72 | 88.42 | 55.52 | 98.09 | 73.43 |
Accrued Expenses | 1,236 | 821.34 | 701.38 | 654.73 | 513.78 | 372.33 |
Current Portion of Long-Term Debt | 633.57 | 220.07 | 113.02 | 54.99 | 40.29 | 37.08 |
Current Portion of Leases | 46.08 | 45.52 | 41.89 | 41.51 | 41.97 | 40.55 |
Current Unearned Revenue | 11.67 | 4.85 | 55.48 | 102.75 | 42.11 | 149.48 |
Other Current Liabilities | - | 258.86 | 186.09 | 58.28 | 31.68 | 22.84 |
Total Current Liabilities | 2,063 | 1,466 | 1,186 | 967.79 | 767.92 | 695.71 |
Long-Term Debt | 2,114 | 2,478 | 2,359 | 2,343 | 2,269 | 1,827 |
Long-Term Leases | 203.29 | 225.09 | 229.54 | 243.1 | 261.34 | 281.35 |
Long-Term Unearned Revenue | - | - | - | 188.18 | 193.79 | 152.36 |
Other Long-Term Liabilities | 10.61 | 7.59 | 398.11 | 308.44 | 212.58 | 98.96 |
Total Liabilities | 4,391 | 4,177 | 4,173 | 4,051 | 3,705 | 3,055 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 1.34 | 1.32 | 1.29 | 1.26 | 1.24 | 1.2 |
Additional Paid-In Capital | 7,812 | 7,510 | 7,388 | 6,811 | 6,455 | 6,058 |
Retained Earnings | -4,165 | -6,703 | -7,288 | -7,010 | -6,569 | -5,438 |
Comprehensive Income & Other | -44.66 | -20.1 | -34.52 | -23.38 | -44.65 | -33.26 |
Shareholders' Equity | 3,604 | 789.18 | 67.09 | -220.64 | -158.22 | 588.2 |
Total Liabilities & Equity | 7,995 | 4,966 | 4,240 | 3,830 | 3,546 | 3,643 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 2,997 | 2,969 | 2,743 | 2,683 | 2,613 | 2,186 |
Net Cash (Debt) | 590.4 | -60.31 | -48.92 | -243.24 | -420.15 | 249.87 |
Net Cash Growth | - | - | - | - | - | -11.29% |
Net Cash Per Share | 4.29 | -0.45 | -0.38 | -1.95 | -3.45 | 2.11 |
Filing Date Shares Outstanding | 133.94 | 132.62 | 129.46 | 125.95 | 124.13 | 120.21 |
Total Common Shares Outstanding | 133.88 | 132.38 | 129.29 | 125.79 | 123.93 | 120.18 |
Working Capital | 3,050 | 2,584 | 2,109 | 2,015 | 1,924 | 2,113 |
Book Value Per Share | 26.92 | 5.96 | 0.52 | -1.75 | -1.28 | 4.89 |
Tangible Book Value | 3,604 | 789.18 | 67.09 | -220.64 | -158.22 | 588.2 |
Tangible Book Value Per Share | 26.92 | 5.96 | 0.52 | -1.75 | -1.28 | 4.89 |
Land | - | 9.08 | 9.08 | 9.08 | 9.08 | 9.08 |
Buildings | - | 297.62 | 294.51 | 271.65 | 269.32 | 262.64 |
Machinery | - | 247.12 | 225.2 | 202.89 | 173.1 | 137.86 |
Construction In Progress | - | 40.95 | 7.67 | 30.1 | 14.6 | 80.75 |
Leasehold Improvements | - | 241.08 | 236.69 | 235.41 | 230.85 | 152.05 |